Biomedical, Clinical & Life Sciences

2022 Catalyst for Infant Health Equity

No applicants // Limit: 1 // Tickets Available: 1 

 

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Catalyst for Infant Health Equity program. The purpose of this new program is to support the implementation of existing action plans that apply data-driven policy and innovative systems strategies to reduce infant mortality (IM) disparities in a specific county/jurisdiction. For the purposes of this NOFO, since “county” is not a term used for all geographic areas, the term “jurisdiction” is also used and refers to tribal areas; the District of Columbia; municipalities within Puerto Rico; and similar geographical areas found within the US-affiliated Pacific Islands and Freely Associated States. The goals of the Catalyst for Infant Health Equity program are twofold: 1) to continue reducing overall IM rates in the United States, and 2) to decrease and ultimately eliminate disparities in IM across racial/ethnic groups by achieving steeper declines for groups with the highest rates. To accelerate disparity reduction, this project seeks to move beyond direct services to implementing targeted policy and systems interventions that will focus on one or more specific social determinants of health (SDOH) domains that contribute to IM disparities in a particular county/jurisdiction.

Internal Deadline
External Deadline
04/19/2022
Solicitation Type

2022 Building Mathematical Modeling Workforce Capacity to Support Infectious Disease and Healthcare Research

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this notice of funding opportunity is to support pre-doctoral fellows’ innovative research to develop and apply computational tools and mathematical methods for modeling the spread of pathogens in healthcare settings (e.g., SARS-CoV-2, healthcare-associated infections [HAIs], antimicrobial resistant organisms [AROs]). This NOFO is intended to increase the number of junior modeling professionals that are trained and experienced in modeling transmission of pathogens in healthcare settings and to contribute to generalizable scientific knowledge through dissemination (e.g., pre-prints, peer-reviewed studies, scientific presentations). The application should be written by the PI/mentor who may or may not name specific pre-doctoral student(s) to conduct the research at the time of application submission.

Internal Deadline
External Deadline
05/04/2022

2022 Modernizing Environmental Public Health Tracking to Advance Environmental Health Surveillance

No applicants // Limit: 1 // Tickets Available: 1 


Only one application per organization will be considered for either Components A and B or Components A, B, and C. Applicants must submit one application, but with separate work plans and budgets for each component.

The Centers for Disease Control and Prevention (CDC), National Center for Environmental Health, Division of Environmental Health Science and Practice announces the availability of fiscal year (FY) 2022 funds for a cooperative agreement to strengthen and modernize environmental health data and surveillance in the United States. The purpose of the funding is to continue building public health capacity and expertise in environmental health surveillance and to modernize data systems to empower public health practitioners, healthcare providers, community members, policy members, and others to make information-driven decisions that affect their health. Since 2002, the Environmental Public Health Tracking Program has provided the United States with accurate and timely standardized information from a nationwide network of environmental health data to help drive actions to improve the health of communities. The information is shared via a network of people and the Environmental Public Health Tracking Network, a web-based system of integrated health and environmental data with components at the national, state, and local levels.

Internal Deadline
External Deadline
05/01/2022

US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings

No applicants // Limit: 1 // Tickets Available: 1 

 

Influenza and other respiratory illnesses, including COVID-19, are important causes of morbidity, mortality, and healthcare burden across all age groups. For influenza and novel vaccines, such as for COVID-19, estimates of vaccine effectiveness in preventing illness and associated complications are needed in order to evaluate the protection provided by nationwide vaccination programs. The goal of this notice of funding opportunity is to support a network of US institutions that can: a) conduct systematic testing for laboratory-confirmed disease due to influenza, SARS-CoV-2 and other respiratory virus infections, b) obtain reliable vaccination information for enrolled patients and c) provide accurate estimates of the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2 and other respiratory viruses, to prevent medically attended influenza-associated illness in the population for whom vaccination is recommended.

Internal Deadline
External Deadline
05/09/2022

RFA-AI-22-019: 2022 Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this Funding Opportunity Announcement (FOA) is to support pandemic preparedness by providing an opportunity for facility improvements and building systems upgrades at existing BSL3 and BSL4 biocontainment laboratories engaged in research on RNA viruses of pandemic potential to facilitate the conduct of biomedical research on vaccines and therapeutics. NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for the 2019 Novel Coronavirus (COVID-19), and within the provisions described in the "American Rescue Plan Act of 2021

Limited Submission language from the solicitation:

Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility.

Internal Deadline
External Deadline
04/19/2022

2022 Breast Cancer Alliance Exceptional Project Grants

Ticket #1: G. Mouneimne
Ticket #2: J. Funk

Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including postdocs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant. This award recognizes creative, unique and innovative research and is open to applicants at institutions throughout the contiguous United States. This is a one year grant for a total of $100,000

Limited Submission language from the solicitation: Researchers should coordinate with their institutions, as BCA will accept a maximum of 2 LOIs per institution.

Internal Deadline
External Deadline
04/01/2022
Solicitation Type

HRSA-22-054: 2022 Health Workforce Research Center Cooperative Agreement Program

This opportunity is Institutionally Coordinated to prevent overlapping topic area submissions.

The Health Resources and Services Administration (HRSA) is accepting applications for the Fiscal Year (FY) 2022 Health Workforce Research Center (HWRC) Cooperative Agreement Program. The purpose of this program is to support and disseminate rigorous research that strengthens evidence-based policy and enhances understanding of issues and trends in the health workforce.

Limited submission language in the solicitation:

NOTE: Multiple applications from an organization with the same DUNS number or Unique Entity Identifier (UEI) are allowable if the applications propose separate and distinct projects and the applicants meet the two following conditions:

  1. Each campus of the applicant organization is allowed to submit one application per HWRC topic area (from Section I.1 of this notice). A campus is defined as a division of a university that has the same name yet is separate with its own grounds, buildings (e.g., school of nursing) and faculty; a single department or agency of a state or local government. For example, the University of ABC – Springfield and the University of ABC – Goldboro can each submit an application for the same HWRC topic area under this program.
  2. You can submit only one application per campus for each of the eight (8) HWRC topic areas identified in Section I.1. For example, the University of ABC – Springfield can submit one application for the Health Equity in the Health Workforce topic area AND one application for the Behavioral Health Workforce topic area. Alternatively, the University of ABC – Springfield can submit one application for the Health Equity in the Health Workforce topic area, and the University of ABC – Goldboro can submit one application for the Behavioral Health Workforce topic area.
Internal Deadline
External Deadline
04/14/2022

2023 Pew Biomedical Scholars

Z. Dai

UA is invited to nominate one candidate. Note: candidates may not be nominated for the Pew Biomedical Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year. The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. Eligibility:

  • As of Sept. 8, 2022, hold a full-time appointment at the rank of assistant professor. (Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible).
  • Must not have been appointed as an assistant professor at any institution prior to June 13, 2018, whether or not such an appointment was on a tenure track.

Internal peer review to select the UArizona nomination for the Pew Biomedical Scholar and the Pew-Stewart Scholar for Cancer Research will be managed by RDS in partnership with the UA Foundation, UAHS, and the UACC.

Internal Deadline
External Deadline
05/18/2022 (Nomination)
Solicitation Type